Toric Intraocular Lens Implantation in Pediatric Cataract
TILIPC
A Prospective Randomized Controlled Trial of Toric Intraocular Lens Implantation in Pediatric Cataractous Eyes
TILIPC
A Prospective Randomized Controlled Trial of Toric Intraocular Lens Implantation in Pediatric Cataractous Eyes
Sponsor study identifier
interventional
40
1 country
2
Study Start
March 1, 2024
Actual (reported)Primary Completion
February 5, 2025
Actual (reported)Study Completion
March 16, 2026
Actual (reported)To evaluate the visual and refractive outcomes after an intraocular lens (IOL) implantation in pediatric eyes with cataract and preexisting corneal astigmatism
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 16, 2026
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 28, 2024
Actual (reported)March 1, 2024
Actual (reported)March 6, 2024
Actual (reported)February 5, 2025
Actual (reported)March 16, 2026
Actual (reported)Uncorrected (UCDVA) and corrected (CDVA) distance visual acuity
measured using the Lea symbol visual acuity chart or the Early Treatment of Diabetic Retinopathy Study (ETDRS) chart according to the patient\'s age
recorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year)
Uncorrected (UCNVA) and corrected (CNVA) near visual acuity
measured using the Lea symbol visual acuity chart or the ETDRS chart for near according to the patient\'s age
recorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year)
Refraction measurements
obtained with KR-1W Wavefront Analyzer
recorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year)
Keratometry measurements
recorded at each follow-up (on the fifth day, first month, third month, sixth month, and first year)
A folding hydrophobic acrylic IOLs AcrySof IQ Toric SN6ATx and Clareon Toric CNW0Tx
A folding hydrophobic acrylic intraocular lens (IOL) AcrySof IQ SN60WF and Clareon SY60WF
All procedures are performed under general anesthesia according to the standard technique of congenital/pediatric cataract surgery with an intraocular lens (IOL) implantation. Paracentesis is performed at 2.30 o\'clock using a 20-gauge straight microvitreoretinal (MVR) knife; a high molecular weight ophthalmic viscosurgical devices (OVD) is injected into the anterior chamber. Then a 2.4 mm corneal tunnel incision is made at 11 o'clock with a disposable keratome knife 2.2 mm. Circular continuous capsulorhexis (≈ 5.5 mm). Сortical cleaving hydrodissection is followed by bimanual phacoaspiration in irrigation-aspiration mode. OVD is injected in the anterior chamber and an IOL is implanted in the capsular bag. Residual OVD is aspirated from the anterior chamber and behind the IOL and followed by IOL alignment. The surgery is completed with corneal hydration at the tunnel incision site.
Kazakh Eye Research Institute
Almaty, 050012, Kazakhstan
Kazakh Eye Research Institute
Astana, 010000, Kazakhstan
Kairat Ruslanuly, MD
Kazakh Eye Research Institute
40 participants (actual enrollment reported by the registry).
First Submitted
February 28, 2024
First Posted
March 6, 2024
Study Start
March 1, 2024
Actual (reported)A folding hydrophobic acrylic IOLs AcrySof IQ SN60WF and Clareon SY60WF for the non-toric group (Alcon Laboratories, Inc.) ARE implanted.
A folding hydrophobic acrylic IOLs AcrySof IQ Toric SN6ATx and Clareon Toric CNW0Tx for the toric group (Alcon Laboratories, Inc.) were implanted.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
February 5, 2025
Actual (reported)Study Completion
March 16, 2026
Actual (reported)Last Updated
October 16, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: